TG
EW icon

TLP Group’s Edwards Lifesciences EW Stock Holding History

TLP Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,040
Closed -$118K – 159
2018
Q3 		$118K Buy
2,040
+1,266
+164% +$61.9K 0.19% 82
2018
Q2 		$38K Buy
+774
New +$36.1K 0.06% 206
2017
Q4 		– Sell
-27
Closed -$1K – 643
2017
Q3 		$1K Buy
+27
New +$1.03K ﹤0.01% 532
2016
Q3 		– Sell
-1,569
Closed -$52K – 325
2016
Q2 		$52K Buy
+1,569
New +$53.7K 0.04% 263

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

TLP Group's EW Position: Q4 2018 in Review

TLP Group sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 2,040 shares — an estimated $118K sold.

TLP Group first reported a position in EW in Q2 2016 and held it in 4 quarters. The position peaked at $118K in Q3 2018. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

  • TLP Group reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 2,040 Edwards Lifesciences shares in Q4 2018, an estimated $118K.
  • TLP Group first reported a position in Edwards Lifesciences in Q2 2016 and held it in 4 quarters.
  • TLP Group's Edwards Lifesciences position peaked at $118K in Q3 2018.
  • 875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.